| Trial ID: | L4632 |
| Source ID: | NCT00157508
|
| Associated Drug: |
Nitroaspirin
|
| Title: |
Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Early Nephropathy
|
| Interventions: |
DRUG: nitroaspirin
|
| Outcome Measures: |
Primary: Albuminuria after 4 weeks of treatment|Insulin sensitivity after 4 weeks of treatment|Cardiac and renal hemodynamics after 4 weeks of treatment |
|
| Sponsor/Collaborators: |
Sponsor: Mario Negri Institute for Pharmacological Research
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
13
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: PREVENTION
|
| Start Date: |
2003-03
|
| Completion Date: |
2004-08
|
| Results First Posted: |
|
| Last Update Posted: |
2015-04-09
|
| Locations: |
Clinical Research Center for Rare Diseases, Ranica, Bergamo, 24020, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT00157508
|
